Cargando…
Prevalence of Primary Drug Resistance Against HIV-1 Integrase Inhibitors in Canada
Autores principales: | Ji, Hezhao, Patterson, Aileen, Taylor, Tracy, Rank, Claudia, Halverson, Jessica, Capina, Rupert, Brooks, James, Sandstrom, Paul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JAIDS Journal of Acquired Immune Deficiency Syndromes
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5902129/ https://www.ncbi.nlm.nih.gov/pubmed/29424788 http://dx.doi.org/10.1097/QAI.0000000000001649 |
Ejemplares similares
-
A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance
por: Taylor, Tracy, et al.
Publicado: (2019) -
Point-of-Care Tests for HIV Drug Resistance Monitoring: Advances and Potentials
por: Chua, Rayeil J., et al.
Publicado: (2022) -
A23 Large phylogenetic clusters highlight the HIV-1 epidemic in Canadian at risk populations
por: Capina, Rupert, et al.
Publicado: (2018) -
A Robust PCR Protocol for HIV Drug Resistance Testing on Low-Level Viremia Samples
por: Gupta, Shivani, et al.
Publicado: (2017) -
Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing
por: Jennings, Cheryl, et al.
Publicado: (2020)